Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effect of Metformin on Gut Peptides , Bile Acids and Lipid Profiles in Type 2 Diabetics

This study has been completed.
Information provided by (Responsible Party):
GlaxoSmithKline Identifier:
First received: November 4, 2010
Last updated: August 14, 2014
Last verified: August 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2011
  Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):